Acessibilidade / Reportar erro

Relationship between microalbuminuria and cardiac structural changes in mild hypertensive patients

Abstract

The aim of this study was to determine the relationship between urinary albumin excretion (UAE), cardiac structural changes upon echocardiography and 24-h ambulatory blood pressure (ABPM) levels. Twenty mild hypertensive patients (mean age 56.8 ± 9.6 years) were evaluated. After 2 weeks of a washout period of all antihypertensive drugs, all patients underwent an echocardiographic evaluation, a 24-h ABPM and an overnight urine collection. Systolic and diastolic blood pressure during 24-h ABPM was 145 ± 14/91 ± 10 mmHg (daytime) and 130 ± 14/76 ± 8 mmHg (nighttime), respectively. Seven (35%) patients presented UAE > or = 15 µg/min, and for the whole group, the geometric mean value for UAE was 10.2 x/÷ 3.86 µg/min. Cardiac measurements showed mean values of interventricular septum thickness (IVS) of 11 ± 2.3 mm, left ventricular posterior wall thickness (PWT) of 10 ± 2.0 mm, left ventricular mass (LVM) of 165 ± 52 g, and left ventricular mass index (LVMI) of 99 ± 31 g/m². A forward stepwise regression model indicated that blood pressure levels did not influence UAE. Significant correlations were observed between UAE and cardiac structural parameters such as IVS (r = 0.71, P<0.001), PWT (r = 0.64, P<0.005), LVM (r = 0.65, P<0.005) and LVMI (r = 0.57, P<0.01). Compared with normoalbuminuric patients, those who had microalbuminuria presented higher values of all cardiac parameters measured. The predictive positive and negative values of UAE > or = 15 µg/min for the presence of geometric cardiac abnormalities were 75 and 91.6%. These data indicate that microalbuminuria in essential hypertension represents an early marker of cardiac structural damage.

Hypertension; Microalbuminuria; Left ventricular hypertrophy; Blood pressure monitoring


Braz J Med Biol Res, July 2002, Volume 35(7) 799-804

Relationship between microalbuminuria and cardiac structural changes in mild hypertensive patients

F.L. Plavnik, M.A.M.R.T. Silva, N.E.B. Kohlmann, O. Kohlmann Jr., A.B. Ribeiro and M.T. Zanella

Divisão de Nefrologia, Grupo de Hipertensão e Diabetes, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil

Patients and Methods

References

Correspondence and Footnotes Correspondence and Footnotes Correspondence and Footnotes

Abstract

The aim of this study was to determine the relationship between urinary albumin excretion (UAE), cardiac structural changes upon echocardiography and 24-h ambulatory blood pressure (ABPM) levels. Twenty mild hypertensive patients (mean age 56.8 ± 9.6 years) were evaluated. After 2 weeks of a washout period of all antihypertensive drugs, all patients underwent an echocardiographic evaluation, a 24-h ABPM and an overnight urine collection. Systolic and diastolic blood pressure during 24-h ABPM was 145 ± 14/91 ± 10 mmHg (daytime) and 130 ± 14/76 ± 8 mmHg (nighttime), respectively. Seven (35%) patients presented UAE ³15 µg/min, and for the whole group, the geometric mean value for UAE was 10.2 x/÷ 3.86 µg/min. Cardiac measurements showed mean values of interventricular septum thickness (IVS) of 11 ± 2.3 mm, left ventricular posterior wall thickness (PWT) of 10 ± 2.0 mm, left ventricular mass (LVM) of 165 ± 52 g, and left ventricular mass index (LVMI) of 99 ± 31 g/m2. A forward stepwise regression model indicated that blood pressure levels did not influence UAE. Significant correlations were observed between UAE and cardiac structural parameters such as IVS (r = 0.71, P<0.001), PWT (r = 0.64, P<0.005), LVM (r = 0.65, P<0.005) and LVMI (r = 0.57, P<0.01). Compared with normoalbuminuric patients, those who had microalbuminuria presented higher values of all cardiac parameters measured. The predictive positive and negative values of UAE ³15 µg/min for the presence of geometric cardiac abnormalities were 75 and 91.6%. These data indicate that microalbuminuria in essential hypertension represents an early marker of cardiac structural damage.

Key words: Hypertension, Microalbuminuria, Left ventricular hypertrophy, Blood pressure monitoring

Introduction

Several studies have demonstrated that 24-h ambulatory blood pressure monitoring (ABPM) is more closely related to target organ damage than casual measurements (1,2). Cardiac structures assessed by echocardiography such as left ventricular mass index (LVMI), left ventricular mass (LVM) or the relative thickness of left ventricular posterior wall (PWT) and interventricular septum (IVS) have shown good correlations with 24-h systolic blood pressure (3). Not only cardiac structural changes but also other abnormalities in target organs of hypertension such as retinopathy (4) and urinary albumin excretion (UAE) have shown a correlation with ABPM (5).

Increased UAE has been reported to be a strong predictor of cardiovascular events in hypertensive patients. The importance of this finding is not completely clear but it seems that there is an association between UAE and the other cardiovascular risk factors such as obesity, insulin resistance, impaired lipid profile and blood pressure (6-8).

The prevalence of microalbuminuria in untreated hypertensive patients ranges from 20 to 40% according to the method used (9-11). In some studies patients treated with diuretics or beta-blockers showed a prevalence of 25%, while others have described a prevalence of proteinuria in a range of 4 to 16% (12,13). The degree of microalbuminuria was positively correlated with office blood pressure although better correlations have been observed using 24-h ambulatory monitoring. Also, a negative correlation has been detected between UAE and the nocturnal blood pressure fall (14-16). Some clinical studies have shown not only a positive correlation between blood pressure levels and microalbuminuria, but also a positive correlation between microalbuminuria and other target organs of hypertensive disease such as LVM and retinopathy (17,18).

Increased UAE by essential hypertensive patients has been interpreted to be a marker of early intrarenal vascular endothelial dysfunction (19). It may be also a risk factor for renal function deterioration (20). The aim of the present study was to determine the relationship between microalbuminuria, cardiac structural changes and blood pressure levels determined by 24-h ambulatory monitoring, in mild hypertensive patients.

Patients and Methods

Patients of both sexes considered to be mild hypertensives (defined as patients with blood pressure levels below 159 mmHg for systolic pressure and 99 mmHg for diastolic pressure after 2 weeks of withdrawal of their antihypertensive medication and no evidence of target organ damage) were eligible for inclusion. They were seen regularly at 3-month intervals at the Hypertension and Diabetes Outpatient Clinic, Hospital do Rim e Hipertensão. Patients with abnormal fasting glucose (³126 mg/dl) and serum creatinine levels (>1.2 mg/dl), as well as those with abnormalities upon echocardiogram evaluation or heart disease were not included. A total of 20 patients (6 men/14 women aged 42-70 years) were evaluated. The time since the diagnosis of hypertension ranged from 1 to 47 years (mean of 13.7 ± 10.2 years).

None of the participants had any clinical hypertensive complications. The local Ethics Committee (UNIFESP) approved this protocol which conformed to the guidelines of the Declaration of Helsinki and informed consent was obtained from the subjects.

Blood pressure determinations

Office blood pressure. Blood pressure levels were determined after at least 5 min of rest in the sitting position using a mercury sphygmomanometer. The same physician performed all measurements and a mean of three determinations was used. Systolic and diastolic blood pressure corresponded to phases I and V of the Korotkoff sound, respectively.

Blood pressure monitoring. ABPM was performed using a noninvasive automatic monitor (SpaceLabs, model 90207). We considered the period during which subjects carried out their normal activities as daytime and nighttime as the period of sleeping. Blood pressure was measured every 15 min during the daytime and every 20 min during the nighttime. The data for subjects with less than 80% of valid measurements were excluded from analysis. The measurements of the mean systolic and diastolic blood pressure obtained from this evaluation were used in the subsequent analysis. All participants were asked to perform their normal daily activities.

Echocardiography. Cardiac structures were evaluated with an M-mode and two-dimensional echocardiographic Esaote Biomedica apparatus (Florence, Italy), model SIM 5000, equipped with a 2.5-MHz mechanical transducer. Patients lay in left decubitus with a slight rotation of the chest. The echocardiographic parameters evaluated were PWT, IVS, both measured at diastole, and LVM calculated according to the American Society of Echocardiography (21).

LVMI was obtained by dividing LMV by body surface area and was considered normal when the values were below 110 g/m2 for women and 134 g/m2 for men.

Relative IVS (RIVS) and relative PWT (RPWT) were calculated from the following expressions:

RIVS = 2 x IVS (mm)/LVEDD (mm)

RPWT = 2 x PWT (mm)/LVEDD (mm)

where LVEDD = left ventricle end-diastolic diameter.

Laboratory parameters. All patients had an overnight (12 h) urine sample collected for UAE measurement, using an immunoturbidimetric method with a specific antibody automatized by CobasMira Plus, Roche (Basel, Switzerland).

Statistical analysis

Data were analyzed with the SigmaStat for Windows software, version 1.0 (Jandel Corporation, Chicago, IL, USA). Data are reported as mean ± SD or median and its confidence intervals. Forward stepwise regression analysis was used to identify the variables that could be predictors or determinants of microalbuminuria and cardiac structural changes. The correlation between cardiac and renal variables was determined by Spearman correlation. For further analysis, microalbuminuria values were log transformed to correct the skewing in distribution. The association between microalbuminuria and increased values of cardiac parameters was tested by Fisher's exact test. Differences were considered significant at P<0.05.

Results

Table 1 shows the clinical characteristics of the subjects. Blood pressure levels obtained with 24-h ABPM showed a mean for systolic and diastolic pressure of 145 ± 14/91 ± 10 mmHg (vigil) and 130 ± 14/76 ± 8 mmHg (sleep), respectively, and the median blood pressure fall during sleep was 10.5% (5.2-17.1).

 

Cardiac evaluation showed that 8 patients (40%), 3 men and 5 women, had both IVS and PWT above the normal range and 4 (20.0%), one man and 3 women, had left ventricular hypertrophy when adjusted for sex. The mean values of these parameters for the remaining subjects were within the normal range: IVS - 11 ± 2.3 mm, PWT - 10 ± 2.0 mm, LVM - 165 ± 52 g and LVMI - 99 ± 31 g/m2.

Urinary albumin excretion greater than 15 µg/min (defined as microalbuminuria) was found in 7 (35%) patients and the geometric mean value was 10.2 x/÷ 3.86 µg/min, ranging from 1.5 to 173 µg/min.

When a stepwise regression model was applied, no ABPM values (mean 24-h, vigil and night), age, BMI or duration of hypertension showed any influence on UAE. When the same model was applied to cardiac structures only LVMI was influenced by the time of diagnosis of hypertension and sleeptime diastolic blood pressure (r2 = 0.60, P<0.05). The duration of the hypertensive process could explain 44% of the increases observed in LVMI and the nighttime diastolic blood pressure levels could explain 16%.

The Spearman test indicated a positive and significant correlation between UAE and cardiac measurements such as absolute IVS (r = 0.71, P<0.001) and PWT (r = 0.64, P<0.005) (Figure 1), as well as between UAE and relative IVS (r = 0.52, P<0.02) and PWT (r = 0.49, P<0.03) (Figure 2). Urinary albumin excretion was also correlated with LVM (r = 0.65, P<0.005) and LVMI (r = 0.57, P<0.01).

A comparison between normoalbuminuric (N = 13) and microalbuminuric (N = 7) patients showed no differences regarding age, BMI, duration of hypertension or blood pressure values determined during ABPM (Table 2). In contrast, the cardiac parameters indicated statistically significant differences between groups (Table 3).

 

 

Microalbuminuria (UAE >15 µg/min) showed a positive predictive value of 75% and a negative predictive value of 91.6% (Table 4) for geometric cardiac abnormalities.

 

Figure 1.
Correlations of microalbuminuria with interventricular septum thickness (IVS) and with left ventricular posterior wall thickness (PWT) for 20 patients.

[View larger version of this image (18 K GIF file)]

Figure 2.
Correlations of microalbuminuria with relative left ventricular wall thickness (RPWT) and with relative interventricular septum thickness (RIVS) for 20 patients.

[View larger version of this image (19 K GIF file)]

Discussion

Microalbuminuria has been considered to be a marker of cardiovascular risk in diabetic (22,23) and non-diabetic subjects (6). The importance of increased UAE levels in essential hypertension is unclear. However, increased UAE has been related not only to blood pressure levels (24) and left ventricular hypertrophy (17) but also to several other risk factors such as hyperinsulinemia, dislipidemia and obesity, which comprise a cluster of metabolic abnormalities (8,15,25,26).

In the present study, UAE was not explained by any of the variables included in a regression model, such as age, duration of hypertension, or BMI. These findings are consistent with the data reported by Palatini et al. (26). In contrast to some reports (20,27), our results did not show any correlation between UAE and blood pressure. This suggests that UAE is not directly dependent on blood pressure levels but depends on renal vascular damage secondary to the hypertensive process.

The association between UAE levels and LVMI demonstrated in our patients has also been reported in untreated hypertensives and in patients with white coat hypertension (28,29). In our study, correlations were also detected between absolute or relative IVS and PWT values and UAE. These findings indicate that UAE is associated with concentric cardiac remodeling, the structural change that precedes the development of left ventricular hypertrophy. This finding supports data reported by Pontremoli et al. (30) who also reported a higher prevalence of unfavorable left ventricular geometric patterns in microalbuminuric patients. The comparison between normoalbuminuric and microalbuminuric subjects confirms our hypothesis that microalbuminuria is a marker of early cardiac changes, as previously suggested in the literature (31). As shown by Bulatov et al. (32), there is a continuous relationship between albumin excretion rate, LVM assessed by echocardiography, and ambulatory blood pressure in newly diagnosed patients with essential hypertension. This suggests that the early effects of blood pressure on target organs such as kidneys and heart occur in parallel (32). The presence of microalbuminuria has been understood to be a renal manifestation of generalized increased endothelial dysfunction.

Our data agree with observations suggesting that determination of UAE is useful for the identification of a subset of patients who could be more prone to developing left ventricular hypertrophy, contributing to the stratification of cardiovascular risk in hypertensive patients (25,27,33,34).

The presence of increased UAE levels in mild hypertension and its association with cardiac structure abnormalities may be considered to be not only evidence of early renal vascular damage, but also as a marker of geometric cardiac changes.

Taking into account the positive predictive value found in this study, the presence of microalbuminuria in hypertensive subjects seems to be a very important test to be considered in the evaluation of cardiovascular risk in this population.

Address for correspondence: F.L. Plavnik, Divisão de Nefrologia, EPM, UNIFESP, Rua Borges Lagoa, 960, 04038-002 São Paulo, SP, Brasil. Fax: +55-11-5579-2985. E-mail: fplavnik@zaz.com.br

Publication supported by FAPESP. Received July 19, 2001. Accepted May 22, 2002.

  • 1. Perloff D, Sokolow M & Cowan R (1983). The prognostic value of ambulatory blood pressure. Journal of the American Medical Association, 249: 2792-2798.
  • 2. White WB (1991). Relationship among casual and ambulatory blood pressure and target organ involvement in essential hypertension. Clinical and Investigative Medicine, 14: 224-230.
  • 3. Rowlands DB, Ireland MA, Glover DR, McLeay RAB, Stallard TJ & Littler WA (1981). The relationship between ambulatory blood pressure and echocardiographically assessed left ventricular hypertrophy. Clinical Science, 61 (Suppl 7): 101S-103S.
  • 4. Perloff D & Sokolow M (1990). Ambulatory blood pressure: the San Francisco experience. Journal of Hypertension, 8 (Suppl 6): S105-S111.
  • 5. Veerman DP, de Blok K & van Montfrans GA (1996). Relationship of steady state and ambulatory blood pressure variability to left ventricular mass and urinary albumin excretion in essential hypertension. American Journal of Hypertension, 9: 455-460.
  • 6. Yudkin JS, Forrest RD & Jackson CA (1988). Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet, ii: 530-533.
  • 7. Ferranini E (1993). The metabolic syndrome. In: Mogensen CE (Editor), Target Organ Damage in the Mature Hypertensive Part 2. Science Press Ltd., London, England, 31-49.
  • 8. Mogensen CE (1994). Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. Journal of Internal Medicine, 235: 297-316.
  • 9. Ljungman S (1990). Microalbuminuria in essential hypertension. American Journal of Hypertension, 3: 956-960.
  • 10. Bigazzi R, Bianchi S, Campese V & Baldari G (1992). Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron, 152: 373-377.
  • 11. Perera GA (1995). Hypertensive vascular disease: description and natural history. Journal of Chronic Diseases, 1: 33-42.
  • 12. Ruilope LM, Alcazar JM & Rodicio JL (1992). Renal consequences of arterial hypertension. Journal of Hypertension, 10 (Suppl 7): S85-S90.
  • 13. Samuelsson O (1985). Hypertension in middle-aged man: management, morbidity and prognostic factors during long-term hypertensive care. Acta Medica Scandinavica, 702 (Suppl): 1-79.
  • 14. Bianchi S, Bigazzi R, Baldari G, Sgherri G & Campese VM (1994). Diurnal variations of blood pressure and microalbuminuria in essential hypertension. American Journal of Hypertension, 7: 23-29.
  • 15. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM & Cooper RS (1994). Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. Journal of Hypertension, 12: 947-953.
  • 16. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C & Ghione S (1989). Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. American Journal of Hypertension, 2: 259-261.
  • 17. Redon J, Gomez-Sanchez MA, Baldo E, Casal MC, Fernandez ML, Miralles A, Gomez-Pajuelo C, Rodicio JL & Ruilope LM (1991). Microalbuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. Journal of Hypertension, 9 (Suppl 6): S148-S149.
  • 18. Biesenbach G & Zazgornik J (1994). High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clinical Nephrology, 41: 211-218.
  • 19. Minram A, Ribstein J & DuCalair G (1994). Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension, 23 (Part 2): 1018-1021.
  • 20. Cerasola G, Cottone S, Mulé G, Nardi E, Mangano MT, Andronico G, Contorno A, Li Vecchi M, Galione P, Renda F, Piazza G, Volpe V, Lisi A, Ferrara L, Panepinto N & Riccobene R (1996). Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. Journal of Hypertension, 14: 915-920.
  • 21. Sahn DJ, DeMaria A, Kisslo J & Weyman A (1978). The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation, 58: 1072-1083.
  • 22. Mogensen CE (1984). Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. New England Journal of Medicine, 310: 356-360.
  • 23. Deckert T, Koford-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rassmussen B & Jensen T (1992). Microalbuminuria. Implications for micro- and macrovascular disease. Diabetes Care, 15: 1181-1191.
  • 24. Parving HH, Jensen H, Mogensen CE & Ervin PE (1974). Increased urinary albumin excretion rate in benign essential hypertension. Lancet, i: 1190-1192.
  • 25. Redon J, Miralles A, Pascual JM, Baldó E, Robles RG & Carmena R (1997). Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension. Journal of Hypertension, 15: 79-86.
  • 26. Palatini P, Graniero GR, Canali C, Santonastaso M, Mos L, Piccolo D, D'Este D, Berton G, Zanata G & De Venuto G (1995). Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension. Journal of Hypertension, 13: 1796-1800.
  • 27. Pontremoli R, Nicolella C, Viazzi F, Ravera M, Sofia A, Berruti V, Bezante GP, Del Sette M, Martinoli C, Sacchi G & Deferrari G (1998). Microalbuminuria is an early marker of target organ damage in essential hypertension. American Journal of Hypertension, 11 (Part 1): 430-438.
  • 28. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G & Pessina AC (1998). Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension. Results from the HARVEST study. Hypertension, 31 (Part 1): 57-63.
  • 29. Cerasola G, Cottone S, D'Ignoto G & Grasso L (1992). Microalbuminuria points out early renal and cardiovascular changes in essential hypertension. Revista Latina de Cardiologia, 13: 3-7.
  • 30. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, Leoncini G, Del Sette M, Brunelli C, Tomolillo C & Deferrari G (1999). Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. Journal of Hypertension, 17: 993-1000.
  • 31. Brakris GL (2001). Microalbuminuria: what is it? Why is it important? What should be done about it? Journal of Clinical Hypertension, 3: 99-102.
  • 32. Bulatov VA, Stenehjem A & Os I (2001). Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension. Journal of Hypertension, 19: 1473-1478.
  • 33. Janssen WMT, de Jong PE & de Zeeuw D (1996). Hypertension and renal disease: role of microalbuminuria. Journal of Hypertension, 14 (Suppl 5): S173-S177.
  • 34. Post WS, Blumenthal RS, Weiss JL, Levine DM, Thiemann DR, Gerstenblith G & Hill MN (2000). Spot urinary albumin-creatinine ratio predicts left ventricular hypertrophy in young hypertensive African-American men. American Journal of Hypertension, 13: 1168-1172.
  • Correspondence and Footnotes

  • Publication Dates

    • Publication in this collection
      16 July 2002
    • Date of issue
      July 2002

    History

    • Accepted
      22 May 2002
    • Received
      19 July 2001
    Associação Brasileira de Divulgação Científica Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto SP Brazil, Tel. / Fax: +55 16 3315-9120 - Ribeirão Preto - SP - Brazil
    E-mail: bjournal@terra.com.br